Cargando…
Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients
Multiple sclerosis (MS) is a chronic, severe disease, characterized by a progressive alteration in neuronal transmission, which decreases personal independence and quality of life (QoL). This study aimed to investigate the relationship between QoL and personal autonomy in patients with MS, as well a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290289/ https://www.ncbi.nlm.nih.gov/pubmed/32380685 http://dx.doi.org/10.3390/jcm9051349 |
_version_ | 1783545641032482816 |
---|---|
author | Padureanu, Rodica Albu, Carmen Valeria Pirici, Ionica Mititelu, Radu Razvan Subtirelu, Mihaela Simona Turcu-Stiolica, Razvan Aurelian Sintonen, Harri Padureanu, Vlad Turcu-Stiolica, Adina |
author_facet | Padureanu, Rodica Albu, Carmen Valeria Pirici, Ionica Mititelu, Radu Razvan Subtirelu, Mihaela Simona Turcu-Stiolica, Razvan Aurelian Sintonen, Harri Padureanu, Vlad Turcu-Stiolica, Adina |
author_sort | Padureanu, Rodica |
collection | PubMed |
description | Multiple sclerosis (MS) is a chronic, severe disease, characterized by a progressive alteration in neuronal transmission, which decreases personal independence and quality of life (QoL). This study aimed to investigate the relationship between QoL and personal autonomy in patients with MS, as well as its correlation with age, educational level, and diseases severity. Twenty-six MS patients were followed-up for six months. All patients completed the 15D questionnaire two times: at T0, when they started a new treatment, and at T1 after six months of treatment. At the end point, all patients completed the Personal Autonomy Questionnaire. The average patient age was 43 years (SD = 10), and 89% of them were female. The mean severity and duration of MS were 3.5 (SD = 1.75) and 9.5 (SD = 5.1), respectively. The average QoL of MS patients at T0 was 0.66 (SD = 0.18), and that at T1 was 0.71 (SD = 0.16). The scores of patients with different types of MS, i.e., relapsing–remitting MS (RRMS) or secondary progressive MS (SPMS), were compared. SPMS patients were older than RRMS patients (mean age 47.5 vs. 39.7 years; p = 0.032), and more RRMS patients were working (0.014). SPMS patients described the same QoL and personal autonomy as RRMS patients. Results from bivariate correlation analyses showed a significant relationship between QoL and age, education, and severity of MS. Also, the analysis showed no significant correlation between QoL and personal autonomy. |
format | Online Article Text |
id | pubmed-7290289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72902892020-06-15 Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients Padureanu, Rodica Albu, Carmen Valeria Pirici, Ionica Mititelu, Radu Razvan Subtirelu, Mihaela Simona Turcu-Stiolica, Razvan Aurelian Sintonen, Harri Padureanu, Vlad Turcu-Stiolica, Adina J Clin Med Article Multiple sclerosis (MS) is a chronic, severe disease, characterized by a progressive alteration in neuronal transmission, which decreases personal independence and quality of life (QoL). This study aimed to investigate the relationship between QoL and personal autonomy in patients with MS, as well as its correlation with age, educational level, and diseases severity. Twenty-six MS patients were followed-up for six months. All patients completed the 15D questionnaire two times: at T0, when they started a new treatment, and at T1 after six months of treatment. At the end point, all patients completed the Personal Autonomy Questionnaire. The average patient age was 43 years (SD = 10), and 89% of them were female. The mean severity and duration of MS were 3.5 (SD = 1.75) and 9.5 (SD = 5.1), respectively. The average QoL of MS patients at T0 was 0.66 (SD = 0.18), and that at T1 was 0.71 (SD = 0.16). The scores of patients with different types of MS, i.e., relapsing–remitting MS (RRMS) or secondary progressive MS (SPMS), were compared. SPMS patients were older than RRMS patients (mean age 47.5 vs. 39.7 years; p = 0.032), and more RRMS patients were working (0.014). SPMS patients described the same QoL and personal autonomy as RRMS patients. Results from bivariate correlation analyses showed a significant relationship between QoL and age, education, and severity of MS. Also, the analysis showed no significant correlation between QoL and personal autonomy. MDPI 2020-05-05 /pmc/articles/PMC7290289/ /pubmed/32380685 http://dx.doi.org/10.3390/jcm9051349 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Padureanu, Rodica Albu, Carmen Valeria Pirici, Ionica Mititelu, Radu Razvan Subtirelu, Mihaela Simona Turcu-Stiolica, Razvan Aurelian Sintonen, Harri Padureanu, Vlad Turcu-Stiolica, Adina Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients |
title | Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients |
title_full | Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients |
title_fullStr | Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients |
title_full_unstemmed | Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients |
title_short | Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients |
title_sort | personal autonomy as quality of life predictor for multiple sclerosis patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290289/ https://www.ncbi.nlm.nih.gov/pubmed/32380685 http://dx.doi.org/10.3390/jcm9051349 |
work_keys_str_mv | AT padureanurodica personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT albucarmenvaleria personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT piriciionica personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT mititeluradurazvan personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT subtirelumihaelasimona personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT turcustiolicarazvanaurelian personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT sintonenharri personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT padureanuvlad personalautonomyasqualityoflifepredictorformultiplesclerosispatients AT turcustiolicaadina personalautonomyasqualityoflifepredictorformultiplesclerosispatients |